Investors Shareholders

About
Teams
Responsibility
Investments
Media

Current portfolio

Pharvaris

Development of drugs for orphan diseases

Sector
Healthcare
Country
Germany
Fund
LSP 5
Entry
2016
Web
pharvaris.com

Sector
Healthcare
Country
Germany
Fund
LSP 5
Entry
2016
Web
pharvaris.com

Latest news

02 June 2023
EQT Private Equity and ADIA agree recommended cash acquisition with Dechra Pharmaceuticals PLC
30 May 2023
Bulletin from EQT AB’s Annual Shareholders’ Meeting 2023
29 May 2023
Francesco Starace to join EQT Infrastructure as Partner – brings deep experience and expertise in energy and transition related industries
15 May 2023
EQT launches EQT Nexus: Enabling individuals’ access to the world of EQT
12 May 2023
EQT Infrastructure to acquire a majority stake in Italy’s largest mobile network from Wind Tre

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of newsRegulatory NewsEQT News

Preferred languageEnglishSwedish

Email address

Offices

Europe
North America
- New York
- San Francisco
APAC

About

EQT Playbook
Fund investors
Purpose and Culture
EQT Foundation
- EQT Foundation
Careers
- Life at EQT
- EQT Academy
Motherbrain

Teams

Roles

Responsibility

Future-proofing
- Climate Action
- Diversity and Inclusion

Business Segments

Private Capital
Real Assets

Investments

Portfolio

Shareholders

About EQT AB Group
IPO on Nasdaq Stockholm
Reports and Presentations
Corporate Governance
About the Share

Media

Newsroom
- News
- Reports and presentations

Contact

Media
- Press Contact
Follow

Legal

Sustainable Finance Disclosure
Complaints Handling Procedure
Glossary and Definitions
Policies
Cookie Policy
Terms and Conditions

About

Teams

Responsibility

Investments

Shareholders

Media

Contact

Legal

A purpose-driven global investment organization

© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180